Evidence map›Paper›PMID 29442268›Full record

ArticleMolecular and cellular biochemistry2018

Cytoplasmic localization of programmed cell death 4 contributes to its anti-apoptotic function.

Syohei Takaki, Ko Eto

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Syohei TakakiDepartment of Biological Sciences, Graduate School of Science and Technology, Kumamoto University, 2-39-1 Kurokami, Chuo-ku, Kumamoto, 860-8555, Japan.
Ko EtoDepartment of Biological Sciences, Graduate School of Science and Technology, Kumamoto University, 2-39-1 Kurokami, Chuo-ku, Kumamoto, 860-8555, Japan. etoko@gpo.kumamoto-u.ac.jp.
Kumamoto University · JP

Funding

The Ministry of Education, Science, Sports, and Culture of Japan 15H00898The Ministry of Education, Science, Sports, and Culture of Japan 26460276
6 · The paper itself

Abstract

We have demonstrated that the loss of programmed cell death 4 (Pdcd4), a translation inhibitor, induces apoptosis; however, when, where, and how Pdcd4 decreases in response to apoptotic stimuli and, conversely, exerts the anti-apoptotic function within normal cells are incompletely understood. Endogenous Pdcd4 was present in both the cytoplasm and nucleus of cells that survived. In cells that had committed to die by apoptotic stimuli, cytoplasmic Pdcd4 was lost more slowly than was nuclear Pdcd4; eventually, Pdcd4 remaining in the cytoplasm was lost and then apoptotic events were induced. Treatment with leptomycin B led to blocked nuclear export of Pdcd4 in cells exposed to apoptotic stimuli, assuming its translocation from the nucleus to the cytoplasm in the early phase of apoptotic processes. In cells overexpressing Pdcd4, the protein localized exclusively cytoplasmic. Overexpression of Pdcd4 resulted in reduced incidence of apoptosis in cells exposed to apoptotic stimuli compared to control cells. In addition, the expression of Procaspase-3, which is translated from the mRNA targeted by Pdcd4, was suppressed in cells overexpressing Pdcd4. Thus, the localization of Pdcd4 to the cytoplasm may be responsible for the suppression of the target mRNA translation and apoptosis.

Indexed as

ApoptosisActive Transport, Cell NucleusApoptosis Regulatory ProteinsCaspase 3Cell NucleusCytoplasmHeLa CellsHumansProtein BiosynthesisRNA-Binding ProteinsRNA, MessengerApoptosis Regulatory ProteinsCaspase 3PDCD4 protein, humanRNA-Binding ProteinsRNA, MessengerApoptosisCellular fate decisionNucleocytoplasmic translocationPhosphorylationTranslational inhibition

Identifiers

PMID29442268
OpenAlexW2792087244

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.